Search results
Results from the WOW.Com Content Network
Apoaequorin is an ingredient in "Prevagen", which is marketed by Quincy Bioscience as a memory supplement. In 2017, the US Federal Trade Commission (FTC) charged the maker with falsely advertising that the product improves memory, provides cognitive benefits, and is "clinically shown" to work. [ 38 ]
"The marketers of Prevagen preyed on the fears of older consumers experiencing age-related memory loss," said Jessica Rich, director of the FTC's Bureau of Consumer Protection, in a statement.
The SPC is not intended to give general advice about treatment of a condition but does state how the product is to be used for a specific treatment. It forms the basis of information for health professionals to know how to use the specific product safely and effectively. The package leaflet supplied with the product is aimed at end-users. [3]
Further, searches for Apoaequorin and the drug trade name Prevagen on Google search engines lead to Aequorin as a search result. Apoaequorin is of enormous social importance right now because it is in a 'vitamin supplement' being being marketed aggressively as Prevagen on american television screens as a memory enhancing 'drug-like product.'
Off-label use is the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration. [1] Both prescription drugs and over-the-counter drugs (OTCs) can be used in off-label ways, although most studies of off-label use focus on prescription drugs.
The dosage should have a uniform appearance, with an acceptable taste, tablet hardness, and capsule disintegration. It is unlikely that formulation studies will be complete by the time clinical trials commence. This means that simple preparations are developed initially for use in phase I clinical trials.
{{Drug use | state = expanded}} will show the template expanded, i.e. fully visible. {{Drug use | state = autocollapse}} will show the template autocollapsed, i.e. if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar, but if not, it is fully visible.
Apoaequorin is an ingredient in "Prevagen", which is marketed by Quincy Bioscience as a memory supplement. The US Federal Trade Commission (FTC) has charged the maker of false advertising , because they claim marketing statements are not supported by scientific studies.